EGFR and non-small cell lung carcinoma: Cases of NSCLC have been described with epidermal growth factor receptor (EGFR) gene mutation that was metachronously transformed to SCLC after treatment with EGFR‐tyrosine kinase inhibitors (TKIs).4, 5